Release of lubricating synovial surfactant by intra-articular steroid.

This research examines whether glucocorticosteroids, specifically a type called methylprednisolone acetate (MPA), can boost the release of a lubricating surfactant or surface-active phospholipid (SAPL) into a joint area. The results indicate that increased levels of this surfactant can significantly improve joint mobility and may potentially aid in the regulation of cartilage hydration, boost macrophage activity, and aid free-radical elimination.

Study Design and Procedures

• The study was carried out by injecting a typical clinical dosage (100 mg) of methylprednisolone acetate (MPA) mixed with 2.5 ml of saline solution into the weight-supporting right radiocarpal joint of five horses.
• The contralateral joints of each horse were injected with 2.5 ml of saline solution alone to serve as controls for the experiment.
• Synovial fluid, the fluid found between joints, was extracted from all 10 joints prior to injection and again at 16 and 32 hours post-injection. The fluid samples were then analyzed utilizing standardized methods.

Experimental Results

• The results showed that all test joints exhibited an increased level of SAPL, with an average increase of 112% observed after 16 hours and a 76% increase after 32 hours, figures deemed highly significant compared to the control joints.
• A substantial increase was also observed in proteolipid, another potential indicator of surfactant release, after 16 hours.
• A significant amount of proteolipid was also found within the synovial fluid of humans.

Implications and Conclusions

• The research suggests that the administration of intra-articular steroids can significantly improve joint mobility in both horses and humans. This improvement may be partially due to the increased lubrication provided by the SAPL.
• Elevating surfactant levels in joints may also offer potential benefits like controlling cartilage hydration, promoting macrophage function, and supporting the neutralization of oxygen-based free radicals.
• While further research is required, the findings indicate a strong link between glucocorticosteroids and enhanced joint mobility, potentially providing a therapeutic avenue for joint-related issues.